Imaging of vascular biology in the heart

Current Cardiovascular Imaging Reports

Volumn 2, Issue 1, 2009, Pages 40-49

  Tavakoli, Sina ^b   Sadeghi, Mehran M ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867733278     PISSN: 19419066     EISSN: 19419074     Source Type: Journal    
DOI: 10.1007/s12410-009-0006-9     Document Type: Review

References (50)

1. Sadeghi MM: The pathobiology of the vessel wall: implications for imaging. J Nucl Cardiol 2006, 13: 402-414.
2. Libby P: Inflammation in atherosclerosis. Nature 2002, 420: 868-874.
3. Falk E: Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006, 47(Suppl 8): C7-C12.
4. Lusis AJ: Atherosclerosis. Nature 2000, 407: 233-241.
5. Briley-Saebo KC, Mulder WJ, Mani V, et al.: Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J Magn Reson Imaging 2007, 26: 460-479.
6. Sadeghi MM, Schechner JS, Krassilnikova S, et al.: Vascular cell adhesion molecule-1-targeted detection of endothelial activation in human microvasculature. Transplant Proc 2004, 36: 1585-1591.
7. Nahrendorf M, Jaffer FA, Kelly KA, et al.: Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114: 1504-1511.
8. Kelly KA, Nahrendorf M, Yu AM, et al.: In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol 2006, 8: 201-207.
9. Kaufmann BA, Sanders JM, Davis C, et al.: Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007, 116: 276-284.
10. McAteer MA, Schneider JE, Ali ZA, et al.: Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol 2008, 28: 77-83.
11. Li AC, Glass CK: The macrophage foam cell as a target for therapeutic intervention. Nat Med 2002, 8: 1235-1242.
12. Moore KJ, Freeman MW: Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 2006, 26: 1702-1711.
13. Katsuda S, Boyd HC, Fligner C, et al.: Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol 1992, 140: 907-914.
14. Dzau VJ, Braun-Dullaeus RC, Sedding DG: Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 2002, 8: 1249-1256.
15. Narula J, Petrov A, Bianchi C, et al.: Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments. Circulation 1995, 92: 474-484.
16. Johnson LL, Schofield LM, Weber DK, et al.: Uptake of 111In-Z2D3 on SPECT imaging in a swine model of coronary stent restenosis correlated with cell proliferation. J Nucl Med 2004, 45: 294-299.
17. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352: 1685-1695.
18. Hartung D, Sarai M, Petrov A, et al.: Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 2005, 46: 2051-2056.
19. Aikawa M, Libby P: The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004, 13: 125-138.
20. Kolodgie FD, Narula J, Burke AP, et al.: Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol 2000, 157: 1259-1268.
21. Pasterkamp G, Fitzgerald PF, de Kleijn DP: Atherosclerotic expansive remodeled plaques: a wolf in sheep's clothing. J Vasc Res 2002, 39: 514-523.
22. Virmani R, Kolodgie FD, Burke AP, et al.: Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005, 25: 2054-2061.
23. Saam T, Hatsukami TS, Takaya N, et al.: The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology 2007, 244: 64-77.
24. Kircher MF, Grimm J, Swirski FK, et al.: Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 2008, 117: 388-395.
25. Hyafil F, Laissy JP, Mazighi M, et al.: Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration. Arterioscler Thromb Vasc Biol 2006, 26: 176-181.
26. Hyafil F, Cornily JC, Feig JE, et al.: Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 2007, 13: 636-641.
27. Amirbekian V, Lipinski MJ, Briley-Saebo KC, et al.: Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci U S A 2007, 104: 961-966.
28. Tawakol A, Migrino RQ, Bashian GG, et al.: In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006, 48: 1818-1824.
29. Rudd JH, Warburton EA, Fryer TD, et al.: Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002, 105: 2708-2711.
30. Rudd JH, Myers KS, Bansilal S, et al.: (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007, 50: 892-896.
31. Laurberg JM, Olsen AK, Hansen SB, et al.: Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation. Atherosclerosis 2007, 192: 275-282.
32. Kolodgie FD, Petrov A, Virmani R, et al.: Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 2003, 108: 3134-3139.
33. Kietselaer BL, Reutelingsperger CP, Heidendal GA, et al.: Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004, 350: 1472-1473.
34. Sarai M, Hartung D, Petrov A, et al.: Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging. J Am Coll Cardiol 2007, 50: 2305-2312.
35. Elliott JI, Surprenant A, Marelli-Berg FM, et al.: Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol 2005, 7: 808-816.
36. Garcia-Touchard A, Henry TD, Sangiorgi G, et al.: Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol 2005, 25: 1119-1127.
37. Deguchi JO, Aikawa M, Tung CH, et al.: Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 2006, 114: 55-62.
38. Lancelot E, Amirbekian V, Brigger I, et al.: Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol 2008, 28: 425-432.
39. Schafers M, Riemann B, Kopka K, et al.: Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 2004, 109: 2554-2559.
40. Zhang J, Nie L, Razavian M, et al.: Molecular imaging of activated matrix metalloproteinase in vascular remodeling. Circulation 2008, 118: 1953-1960.
41. Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S: Cathepsin cysteine proteases in cardiovascular disease. FASEB J 2007, 21: 3029-3041.
42. Jaffer FA, Kim DE, Quinti L, et al.: Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation 2007, 115: 2292-2298.
43. Chen J, Tung CH, Mahmood U, et al.: In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002, 105: 2766-2771.
44. Kolodgie FD, Gold HK, Burke AP, et al.: Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003, 349: 2316-2325.
45. Moreno PR, Purushothaman KR, Fuster V, et al.: Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004, 110: 2032-2038.
46. Winter PM, Neubauer AM, Caruthers SD, et al.: Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26: 2103-2109.
47. Winter PM, Morawski AM, Caruthers SD, et al.: Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003, 108: 2270-2274.
48. Matter CM, Schuler PK, Alessi P, et al.: Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin. Circ Res 2004, 95: 1225-1233.
49. Sadeghi MM, Krassilnikova S, Zhang J, et al.: Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo. Circulation 2004, 110: 84-90.
50. Zhang J, Krassilnikova S, Gharaei AA, et al.: Alphavbeta3-targeted detection of arteriopathy in transplanted human coronary arteries: an autoradiographic study. FASEB J 2005, 19: 1857-1859.